4.0

OptionMetrics Releases IvyDB US 6.0 and IvyDB ETF 4.0 with Proprietary Methodologies for Faster, More Precise Options Implied Volatilities

Retrieved on: 
Wednesday, March 13, 2024
Research, Technology, Finance, Fintech, Consulting, Professional Services, Software, Data Analytics, Data Management, Science, Microsoft, Methodology, Prevalence, SQL, Name, Jinn, Risk, Linux, PostgreSQL, 4.0, Index, Intravenous therapy, Data management, Computer data storage

OptionMetrics , the leader in financial data and analytics for institutional investors and academic researchers worldwide, releases IvyDB US 6.0 and IvyDB ETF 4.0 .

Key Points: 
  • OptionMetrics , the leader in financial data and analytics for institutional investors and academic researchers worldwide, releases IvyDB US 6.0 and IvyDB ETF 4.0 .
  • In order to better serve its customers amid economic shifts, the prevalence of meme stocks, and need for highly accurate implied volatility calculations to measure risk, OptionMetrics has significantly enhanced its historical end-of-day options data .
  • Improved Index Volatilities – enhances the term structure in option pricing models to produce even more accurate index options vols, implied volatilities, and greeks, and reflection of market conditions.
  • Precise Single Stock Volatilities with Implied Borrowing Costs – for even greater accuracy in put-call IV spreads across the entire universe of single stocks.

Chargeback Gurus Leads the Way as Early Adopter of PCI DSS 4.0 Standards

Retrieved on: 
Tuesday, March 12, 2024
Security, Payments, Technology, Artificial Intelligence, Software, Access control, RBAC, PCI DSS, Certification, 4.0, PCI, Cryptocurrency

Chargeback Gurus , which helps businesses protect and recover revenue by providing innovative chargeback management solutions, today announced its early adoption of the Payment Card Industry Data Security Standard (PCI DSS) version 4.0.

Key Points: 
  • Chargeback Gurus , which helps businesses protect and recover revenue by providing innovative chargeback management solutions, today announced its early adoption of the Payment Card Industry Data Security Standard (PCI DSS) version 4.0.
  • PCI DSS is a global standard that establishes technical and operational criteria for protecting payment data.
  • As merchants entrust Chargeback Gurus with their customer data, security is of utmost importance.
  • “Chargeback Gurus is dedicated to being on the cutting edge of security standards and regulations to ensure a paramount experience for our clients.

EQS-News: Henkel delivers very strong organic sales growth and significant earnings improvement in 2023

Retrieved on: 
Wednesday, March 13, 2024
Adobe, Acquisition, 4.0, Supervisory board, DEI, Investment, Life, SAP, Construction, Marketing, Culture, Growth, Sale, Laundry, Advertising, Volume, Union of Concerned Scientists, Final good, Safety, Nursing care plan, Equity, CO2, Policy, Heart, EPS, Consumer, Persil, Annual, Microsoft, Ambition, Mobility, Renewable energy

Organic sales growth was very strong at 4.2 percent.

Key Points: 
  • Organic sales growth was very strong at 4.2 percent.
  • The Adhesive Technologies business unit generated strong organic sales growth of 3.2 percent, which was driven by the business areas Mobility & Electronics, as well as Craftsmen, Construction & Professional.
  • The Consumer Brands business unit achieved very strong organic sales growth of 6.1 percent, driven particularly by the Laundry & Home Care and Hair business areas.
  • Adjusted return on sales (adjusted EBIT margin) in fiscal 2023 was significantly higher year on year at 11.9 percent (2022: 10.4 percent).

Integrum AB: A new record revenue quarter with 61% growth

Retrieved on: 
Thursday, February 29, 2024
Incidence, Hospital, Disability, 4.0, CMS, PMA, MDR, FDA, Quality of life, Food, Growth, Defense, Amputation, Disclosure, Bionics, Center of excellence, Mercedes-Benz Axor, Syndrome, Medicare, Certification, Ecosystem, Patient, Trial of the century, Osseointegration, Medical device

The growth in the US market is 43% compared with the corresponding period last year.

Key Points: 
  • The growth in the US market is 43% compared with the corresponding period last year.
  • The third quarter has been characterized by record sales figures, mainly driven by our continued expansion in the US and a recent accelerating growth in emerging markets.
  • Integrum is the world's foremost company in in advanced amputation treatment, and we look forward to leading the way in restoring mobility globally.
  • This disclosure contains information that Integrum AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014).

SecurityMetrics Unveils Updated Solutions to Streamline PCI v4.0 Transition

Retrieved on: 
Tuesday, January 16, 2024
SAQ, Organization, 4.0, PCI, SMB, Payment card

OREM, Utah, Jan. 16, 2024 /PRNewswire/ -- SecurityMetrics PCI solutions for merchants and service providers are now accessible to meet the new PCI DSS v4.0 standard.

Key Points: 
  • OREM, Utah, Jan. 16, 2024 /PRNewswire/ -- SecurityMetrics PCI solutions for merchants and service providers are now accessible to meet the new PCI DSS v4.0 standard.
  • All innovations were designed to empower merchants by making PCI v4.0 more approachable and less intimidating through the use of SecurityMetrics solutions.
  • SecurityMetrics' PCI 4.0 available updates are sweeping and cover a variety of topics.
  • What to Expect from a PCI v4.0 Assessment: This webinar offers insights into the PCI 4.0 audit process for enterprise-level organizations.

Global Pharma 4.0 Market to Hit $54.43 Billion by 2031 at 18.3% CAGR: Coherent Market Insights

Retrieved on: 
Tuesday, January 16, 2024
Cloud, Artificial intelligence, Development, Hardware, 4.0, Internet, Honeywell, Health, Microsoft, Component, Intelligence, Google Images, Data science, AI, GE HealthCare, Fourth Industrial Revolution, Cloud computing, Digital, Drug discovery, Data wrangling, Growth, Supply chain management, Investment, Fujitsu, Oracle, Genomics, 3D, Drug development, IBM, Digital health, Therapy, Cisco, Google Cloud, Automation, Research, Internet of things, Pharmacy, Pharmaceutical industry

According to the report, the global artificial intelligence in oncology market generated $16.75 billion in 2023, and is anticipated to generate $54.43 billion by 2031, witnessing a CAGR of 18.3% from 2024 to 2031.

Key Points: 
  • According to the report, the global artificial intelligence in oncology market generated $16.75 billion in 2023, and is anticipated to generate $54.43 billion by 2031, witnessing a CAGR of 18.3% from 2024 to 2031.
  • This has led to an increased need for automation technologies across the pharma value chain from drug discovery to packaging.
  • The driver for automation is expected to further propel the growth of pharma 4.0 market in the coming years.
  • The global pharma 4.0 market is expected to exhibit a CAGR of 18.3% during the forecast period.

Global Pharma 4.0 Market to Hit $54.43 Billion by 2031 at 18.3% CAGR: Coherent Market Insights

Retrieved on: 
Tuesday, January 16, 2024
Cloud, Artificial intelligence, Development, Hardware, 4.0, Internet, Honeywell, Health, Microsoft, Component, Intelligence, Google Images, Data science, AI, GE HealthCare, Fourth Industrial Revolution, Cloud computing, Digital, Drug discovery, Data wrangling, Growth, Supply chain management, Investment, Fujitsu, Oracle, Genomics, 3D, Drug development, IBM, Digital health, Therapy, Cisco, Google Cloud, Automation, Research, Internet of things, Pharmacy, Pharmaceutical industry

According to the report, the global artificial intelligence in oncology market generated $16.75 billion in 2023, and is anticipated to generate $54.43 billion by 2031, witnessing a CAGR of 18.3% from 2024 to 2031.

Key Points: 
  • According to the report, the global artificial intelligence in oncology market generated $16.75 billion in 2023, and is anticipated to generate $54.43 billion by 2031, witnessing a CAGR of 18.3% from 2024 to 2031.
  • This has led to an increased need for automation technologies across the pharma value chain from drug discovery to packaging.
  • The driver for automation is expected to further propel the growth of pharma 4.0 market in the coming years.
  • The global pharma 4.0 market is expected to exhibit a CAGR of 18.3% during the forecast period.

FireMon Leads the Way in PCI DSS 4.0 Compliance

Retrieved on: 
Wednesday, November 29, 2023
Data Management, Security, Technology, Software, Networks, Internet, PCI, 4.0, Automation, PCI DSS, Policy, Organization, NSPM, Audit, Risk management

“Ensuring compliance with the new PCI DSS 4.0 standards is not just a regulatory requirement but a critical step in safeguarding digital assets and maintaining customer trust,” said Jeremy Martin, Chief Technology Officer at FireMon.

Key Points: 
  • “Ensuring compliance with the new PCI DSS 4.0 standards is not just a regulatory requirement but a critical step in safeguarding digital assets and maintaining customer trust,” said Jeremy Martin, Chief Technology Officer at FireMon.
  • "Our real-time compliance management capabilities, enriched by deep insights into network security, uniquely qualify us to guide businesses through the challenges and opportunities presented by PCI DSS 4.0 standards."
  • This helps cement its position as the premier solution for managing network security policies and ensuring PCI DSS 4.0 compliance.
  • Join FireMon as they discuss the latest PCI DSS 4.0 requirements during a webinar on December 5 at 12:00 PM EST.

Pharma 4.0 Market is Booming and Expected to Reach $52.41 Billion by 2031 - Explained Details | Updated InsightAce Study

Retrieved on: 
Wednesday, December 13, 2023
Carnival Corporation & plc, Palo Alto Networks, ABB, COVID-19, 4.0, Automation, Digital, IBM Consulting, Digital transformation, Partnership, Digitalization, Growth, Knowledge, Pharma, Fine chemical

Pharma 4.0 technology also aims to improve decision-making skills and provide in-line, real-time control over business, quality, operations, and regulatory compliance.

Key Points: 
  • Pharma 4.0 technology also aims to improve decision-making skills and provide in-line, real-time control over business, quality, operations, and regulatory compliance.
  • The North American pharma 4.0 market is anticipated to register a major market share in terms of revenue.
  • The development of new technologies is expected to significantly enhance the expansion of the Industry 4.0 market in the region.
  • The introduction of game-changing technology is predicted to cause a surge in the region's Industry 4.0 market.

Pharma 4.0 Market is Booming and Expected to Reach $52.41 Billion by 2031 - Explained Details | Updated InsightAce Study

Retrieved on: 
Wednesday, December 13, 2023
Carnival Corporation & plc, Palo Alto Networks, ABB, COVID-19, 4.0, Automation, Digital, IBM Consulting, Digital transformation, Partnership, Digitalization, Growth, Knowledge, Pharma, Fine chemical

Pharma 4.0 technology also aims to improve decision-making skills and provide in-line, real-time control over business, quality, operations, and regulatory compliance.

Key Points: 
  • Pharma 4.0 technology also aims to improve decision-making skills and provide in-line, real-time control over business, quality, operations, and regulatory compliance.
  • The North American pharma 4.0 market is anticipated to register a major market share in terms of revenue.
  • The development of new technologies is expected to significantly enhance the expansion of the Industry 4.0 market in the region.
  • The introduction of game-changing technology is predicted to cause a surge in the region's Industry 4.0 market.